Title:
CHOLESTEROL-CONTAINING COMPOUNDS AND THEIR USE AS IMMUNOGENS AGAINST BORRELIA BURGDORFERI
Document Type and Number:
WIPO Patent Application WO2004089969
Kind Code:
A3
Abstract:
Unique compounds that can be used for inducing an immune response to Borrelia burgdorferi in a subject by administering a therapeutically effective amount of the glycolipid to the subject. Such administration is particularly useful for preventing or treating Lyme disease in a subject. The compounds(s), and therapeutically acceptable salts thereof, may be formulated into pharmaceutical or immunogenic compositions.
More Like This:
Inventors:
BEN-MENACHEM GIL (US)
KUBLER-KIELB JOANNA (US)
SCHNEERSON RACHEL (US)
ROBBINS JOHN B (US)
POZSGAY VINCE (US)
KUBLER-KIELB JOANNA (US)
SCHNEERSON RACHEL (US)
ROBBINS JOHN B (US)
POZSGAY VINCE (US)
Application Number:
PCT/US2004/010007
Publication Date:
December 16, 2004
Filing Date:
April 02, 2004
Export Citation:
Assignee:
US GOV HEALTH & HUMAN SERV (US)
BEN-MENACHEM GIL (US)
KUBLER-KIELB JOANNA (US)
SCHNEERSON RACHEL (US)
ROBBINS JOHN B (US)
POZSGAY VINCE (US)
BEN-MENACHEM GIL (US)
KUBLER-KIELB JOANNA (US)
SCHNEERSON RACHEL (US)
ROBBINS JOHN B (US)
POZSGAY VINCE (US)
International Classes:
C07J9/00; C07J; (IPC1-7): C07J9/00
Foreign References:
US4189471A | 1980-02-19 | |||
US4229441A | 1980-10-21 | |||
EP0023865A2 | 1981-02-11 |
Other References:
GIL BEN-MENACHEM ET AL.: "A newly discovered cholesteryl galactoside from Borrelia burgdorferi", PNAS, vol. 100, no. 13, 2003, pages 7913 - 7918, XP002300283
N.W.J.SCHRÖDER ET AL.: "Acylated Cholesteryl Galactoside as a Novel Immunogenic Motif in Borrelia burgdorferi Sensu Stricto", J.BIOL.CHEM., vol. 278, no. 36, 2003, pages 33645 - 33653, XP002300284
N.W.J.SCHRÖDER ET AL.: "Acylated Cholesteryl Galactoside as a Novel Immunogenic Motif in Borrelia burgdorferi Sensu Stricto", J.BIOL.CHEM., vol. 278, no. 36, 2003, pages 33645 - 33653, XP002300284
Download PDF:
Previous Patent: PROCESS FOR PRODUCING 2'-DEOXY-2'-FLUOROURIDINE
Next Patent: CRYSTALLINE 19-NORSTEROIDS
Next Patent: CRYSTALLINE 19-NORSTEROIDS